Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Atrial Fibrillation Health Center

Font Size

FDA Advisory Panel Backs Xarelto to Prevent Strokes

Panel Members Recommend Approval of New Blood Thinner for Patients With Atrial Fibrillation
WebMD Health News
Reviewed by Laura J. Martin, MD

Sept. 8, 2011 -- An FDA advisory panel has voted to recommend approval of a new blood thinner to prevent strokes and dangerous blood clots in patients with the heart rhythm disorder atrial fibrillation.

In a vote of nine to two, with one member abstaining, the panel said Xarelto (rivaroxaban) was at least as safe and effective as the older drug warfarin.

Warfarin is also sold under the brand names Coumadin and Jantoven.

The vote puts the panel at odds with the FDA's own reviewers, who recommended against approval in a 388-page report released in advance of the meeting.

The FDA is not required to follow the panel's recommendation, but often does.

"Having treated thousands of patients with atrial fibrillation and dealt with the tremendous problems of using warfarin and patients having issues with warfarin, I think there's a tremendous unmet medical need for new therapies," says panel member Philip Sager, MD, in explaining his vote for approval. Sager is a pharmaceutical consultant and chair of the scientific programs committee of the Cardiac Safety Research Consortium in San Francisco.

Others said they felt "fatal flaws" in the way the drug was studied and lingering questions about the safest way to give it were reasons to vote no.

"When you deal with a morbid, mortal complication like [stroke], we owe patients the best therapy we can get," says panel member Steven Nissen, MD, chair of the department of cardiovascular medicine at the Cleveland Clinic. "It makes me concerned that this may be a step back, rather than a step forward."

The vote was a boost for the drug's developers, Johnson & Johnson and partner Bayer Healthcare. The drugmakers see Xarelto as a potential blockbuster treatment for atrial fibrillation, a condition that's becoming more common in an aging population.

Xarelto was approved in July to prevent blood clots in people having hip and knee replacement surgery.

As many as 2.2 million Americans have atrial fibrillation, a condition that causes the heart to beat in an irregular and uncoordinated way. When that happens, blood may pool and clot in the heart's upper chambers. Those blood clots can then break free and travel to the brain, causing strokes and other dangerous complications.

Studies have shown that people with atrial fibrillation have an increased risk of having a stroke compared to people without the condition.

1 | 2 | 3

Today on WebMD

pacemaker next to xray
Ablation, cardioversion, pacemaker, and more.
human brain
What you need to know.
woman doing yoga
Tips for easing stress.
fish and vegetables
How to eat to protect your heart.
Omega 3 Overview Slideshow
At Risk for Heart Disease
Recognizing Womens Heart Symptoms
Simple Steps to Lower Cholesterol

Resolved To Quit Smoking
Lowering Blood Pressure Slideshow
Heart Disease And Ed
Atrial fibrillation

WebMD Special Sections